Diabetes Mellitus Clinical Trial
Official title:
Controlled Clinical Trial Comparing the Effect of an Achilles Tendon Lengthening Procedure and Casting to Casting Alone for the Treatment of Neuropathic Forefoot Plantar Ulcers in Patients With Diabetes Mellitus
People with diabetes often develop severe skin problems (ulcers) on their feet. Sometimes these are treated with surgery and other times by temporarily immobilizing the foot in a cast. This study compares the effect of surgery to lengthen the Achilles tendon and put the foot in a cast, to using a cast alone. The study will also examine how foot strength, joint movement, and overall ability to walk, balance and climb stairs is affected.
Patients with diabetes mellitus (DM) and peripheral neuropathy are at high risk for forefoot
plantar ulcers and subsequent lower extremity amputation. Total contact casting currently is
the most effective treatment for healing neuropathic plantar ulcers but ulcer recurrence is
high (30-50%) when patients discontinue casting and resume walking. An equinus deformity
(limited ankle dorsiflexion range-of-motion) is associated with these recurrent ulcers.
Although descriptive evidence indicates an Achilles lengthening procedure (which corrects
the equinus deformity) can improve healing rates in these chronic ulcers, there have been no
controlled studies.
This randomized prospective controlled clinical trial will determine if percutaneous
Achilles lengthening and total contact casting is more effective than total contact casting
alone in healing forefoot plantar ulcers (n=30/group will allow detection of 25% effect with
power of 0.8 at alpha level of 0.05). Secondary purposes are to determine the effects of
casting and percutaneous lengthening on measures of impairments, functional limitations, and
disability in patients with DM and peripheral neuropathy. The specific aims of this project
are to determine the effect of the Achilles lengthening procedure on patients with DM,
peripheral neuropathy, a forefoot ulcer, and an equinus deformity in regards to 1) Wound
healing, 2) Impairments (dorsiflexion range-of-motion, plantar flexor muscle performance),
3) Functional Limitations (Physical Performance Test, Functional Reach, walking ability),
and 4) Disability (SF36). The results will have important implications for prevention of
wound infection and lower extremity amputation; and improvement in impairments, functional
limitations, and disability in this group of high risk patients with chronic disease.
Approximately 30 patients will be recruited for each of the treatment groups.
;
Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Treatment
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT03743779 -
Mastering Diabetes Pilot Study
|
||
Completed |
NCT03786978 -
Pharmaceutical Care in the Reduction of Readmission Rates in Diabetes Melitus
|
N/A | |
Completed |
NCT01804803 -
DIgital Assisted MONitoring for DiabeteS - I
|
N/A | |
Completed |
NCT05039970 -
A Real-World Study of a Mobile Device-based Serious Health Game on Session Attendance in the National Diabetes Prevention Program
|
N/A | |
Completed |
NCT04507867 -
Effect of a NSS to Reduce Complications in Patients With Covid-19 and Comorbidities in Stage III
|
N/A | |
Completed |
NCT04068272 -
Safety of Bosentan in Type II Diabetic Patients
|
Phase 1 | |
Completed |
NCT03243383 -
Readmission Prevention Pilot Trial in Diabetes Patients
|
N/A | |
Completed |
NCT03730480 -
User Performance of the CONTOUR NEXT and CONTOUR TV3 Blood Glucose Monitoring System (BGMS)
|
N/A | |
Recruiting |
NCT02690467 -
Efficacy, Safety and Acceptability of the New Pen Needle 34gx3,5mm.
|
N/A | |
Completed |
NCT02229383 -
Phase III Study to Evaluate Safety and Efficacy of Added Exenatide Versus Placebo to Titrated Basal Insulin Glargine in Inadequately Controlled Patients With Type II Diabetes Mellitus
|
Phase 3 | |
Completed |
NCT06181721 -
Evaluating Glucose Control Using a Next Generation Automated Insulin Delivery Algorithm in Patients With Type 1 and Type 2 Diabetes
|
N/A | |
Completed |
NCT05799976 -
Text Message-Based Nudges Prior to Primary Care Visits to Increase Care Gap Closure
|
N/A | |
Recruiting |
NCT04489043 -
Exercise, Prediabetes and Diabetes After Renal Transplantation.
|
N/A | |
Withdrawn |
NCT03319784 -
Analysis for NSAID VS Corticosteroid Shoulder Injection in Diabetic Patients
|
Phase 4 | |
Completed |
NCT03542084 -
Endocrinology Auto-Triggered e-Consults
|
N/A | |
Completed |
NCT02229396 -
Phase 3 28-Week Study With 24-Week and 52-week Extension Phases to Evaluate Efficacy and Safety of Exenatide Once Weekly and Dapagliflozin Versus Exenatide and Dapagliflozin Matching Placebo
|
Phase 3 | |
Recruiting |
NCT05544266 -
Rare and Atypical Diabetes Network
|
||
Completed |
NCT01892319 -
An International Non-interventional Cohort Study to Evaluate the Safety of Treatment With Insulin Detemir in Pregnant Women With Diabetes Mellitus. Diabetes Pregnancy Registry
|
||
Completed |
NCT05031000 -
Blood Glucose Monitoring Systems: Discounter Versus Brand
|
N/A | |
Recruiting |
NCT04039763 -
RT-CGM in Young Adults at Risk of DKA
|
N/A |